162100-95-0

Basic information

• Product Name: 1H-Indole,6-fluoro-5-methyl-(9CI)
• Synonyms: 1H-Indole,6-fluoro-5-methyl-(9CI);6-Fluoro-5-Methyl 1H-indole;5-Methyl-6-fluoro indole
• CAS NO: 162100-95-0
• Molecular Formula: C₉H₈FN
• Molecular Weight: 149.167
• Product Categories: HALIDE
• Mol File: 162100-95-0.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 272.0±20.0 °C(Predicted)
• Appearance: /
• Density: 1.219±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 16.57±0.30(Predicted)
• CAS DataBase Reference: 1H-Indole,6-fluoro-5-methyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Indole,6-fluoro-5-methyl-(9CI)(162100-95-0)
• EPA Substance Registry System: 1H-Indole,6-fluoro-5-methyl-(9CI)(162100-95-0)

Safety Data

• Hazardous Substances Data: 162100-95-0(Hazardous Substances Data)

Usage

General Description

1H-Indole,6-fluoro-5-methyl-(9CI) is a chemical compound with the molecular formula C9H8FN. It belongs to the class of indole derivatives, which are commonly found in natural products and are known for their diverse biological activities. This specific compound is characterized by a fluorine atom at the 6th position and a methyl group at the 5th position of the indole ring. It may have potential applications in the pharmaceutical industry, particularly in the development of new drugs with antibacterial, antifungal, or anticancer properties. However, further research and testing would be needed to fully understand its potential uses and effects.

Upstream product

• 1049685-22-4 6-fluoro-5-methylindole-2-carboxylic acid 
• 1071974-01-0 cyano-(4-fluoro-5-methyl-2-nitrophenyl)acetic acid benzyl ester 

Relevant articles and documents

(AZA)INDOLE DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES

The present invention provides compounds useful as agents for the prevention or treatment of a disease associated with abnormal serum uric acid level which has a uricosuric activity or the like. The present invention relates to (aza)indole derivatives represented by the following general formula (I) having xanthine oxidase inhibitory activities and useful as agents for the prevention or treatment of a disease associated with abnormality of serum uric acid level, prodrugs thereof, or salts thereof. In the formula (I), T represents nitro or cyano and the like; ring J represents aryl or heteroaryl and the like; Q represents carboxy or 5-tetazolyl and the like; Y represents H, OH, NH2, halogen, nitro, alkyl, alkoxy and the like; X1, X2 and X3 independently represent CR2 or N; R1 and R2 independently represent halogen, cyano, haloalkyl, A-D-E-G, -N(-D-E-G)2 and the like, in the formula, A represents a single bond, O, S and the like; D and G independently represent optionally substituted alkylene, cycloalkylene, heterocycloalkylene, arylene, heteroarylene and the like; E represents a single bond, O, S, COO, SO2 and the like.